InMed Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $8,090,444 | $1,172 | $1,240 | $1,689 |
Gross Profit | 1,100,428 | 139 | 324 | 21 |
EBITDA | -7,443,349 | -1,645 | -1,612 | -2,514 |
EBIT | -7,662,497 | -1,796 | -1,764 | -2,664 |
Net Income | -7,655 | -1,722 | -1,478 | -2,536 |
Net Change In Cash | 8,090,444 | 1,172 | 1,240 | 1,689 |
Free Cash Flow | -1,019 | -1,964 | -1,857 | -2,174 |
Cash | 6,571 | 7,600 | 9,534 | 6,738 |
Basic Shares | 7,655 | 9,612 | 7,973 | 3,328 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $8,094,547 | $4,135 | $1,089 | $0 |
Gross Profit | 1,100,913 | 1,403 | 543 | -197 |
EBITDA | -7,448,850 | -7,734 | -13,183 | -9,801 |
EBIT | -7,668,450 | -8,330 | -13,695 | -9,998 |
Net Income | -7,661 | -7,947 | -18,600 | -10,200 |
Net Change In Cash | 8,094,547 | 4,135 | 1,089 | 0 |
Free Cash Flow | -6,995 | -7,445 | -15,622 | -9,792 |
Cash | 6,571 | 8,912 | 6,176 | 7,363 |
Basic Shares | 7,585 | 2,448 | 560 | 270 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.21 |
2024-03-31 | -$0.17 |
2023-12-31 | -$14.03 |
2023-09-30 | -$0.10 |
